FUS-ERG Induces Late-Onset Azacitidine Resistance in Acute Myeloid Leukemia Cells

Scientists investigated whether azacitidine (Aza) was effective against FUS-ERG. Stable Ba/F3 transfectants with FUS-ERG were repeatedly exposed to Aza for 7 days of treatment and at 21-day intervals to investigate Aza sensitivity.